Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroprotective Drugs”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Large-scale testing (Phase 3)Study completedNCT06437626
What this trial is testing

Efficacy and Safety of Mexidol® in Stroke Therapy

Who this might be right for
Ischemic Stroke
Pharmasoft 304
Not applicableLooking for participantsNCT06550167
What this trial is testing

Neuroprotective Effect of (Nano PSO), in Patients Who Used to Consume Psychoactive Substances

Who this might be right for
Addiction;Drug(S);LSDNeuroprotective
Distribuidora Biolife SA de CV 80
Post-approval studies (Phase 4)Looking for participantsNCT06353334
What this trial is testing

Butylphthalide's Safety and Efficacy for Improving Neurological Function Prognosis in Patients With Cardiac Arrest (BNCA Trial)

Who this might be right for
ButylphthalideCardiac ArrestNeuroprotective Drugs
Tang Ziren 100
Testing effectiveness (Phase 2)Looking for participantsNCT06744361
What this trial is testing

Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest

Who this might be right for
Out-of-hospital Cardiac Arrest (OHCA)
Christian Hassager 282
Large-scale testing (Phase 3)Study completedNCT01188811
What this trial is testing

Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Chronic Progressive
VA Office of Research and Development 54
Testing effectiveness (Phase 2)Study completedNCT01910259
What this trial is testing

MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial

Who this might be right for
Secondary Progressive Multiple Sclerosis
University College, London 445
Post-approval studies (Phase 4)Looking for participantsNCT06572085
What this trial is testing

Neuroprotective Effect of Butylphthalide for Cardiac Arrest Patients

Who this might be right for
ButylphthalideCardiac ArrestNeuroprotective Drugs
Tang Ziren 350
Large-scale testing (Phase 3)Looking for participantsNCT07167550
What this trial is testing

The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke

Who this might be right for
StrokeAcute StrokeIschemic Stroke+2 more
Tatchempharmpreparaty, JSC 184
Testing effectiveness (Phase 2)WithdrawnNCT02113176
What this trial is testing

Minocycline as Neuroprotectant After Aneurysmal Subarachnoid Hemorrhage

Who this might be right for
Subarachnoid Aneurysm Hemorrhage
University at Buffalo
Very early researchLooking for participantsNCT06171152
What this trial is testing

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

Who this might be right for
Multiple SclerosisLong COVIDLong Covid19+4 more
University of Chicago 30
Large-scale testing (Phase 3)Study completedNCT00999583
What this trial is testing

High Dose of Erythropoietin Analogue After Cardiac Arrest

Who this might be right for
Comatose Survivors of Cardiac Arrest
Assistance Publique - Hôpitaux de Paris 500
Not applicableNo Longer AvailableNCT03537807
What this trial is testing

Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisALSLou Gehrig Disease+3 more
Biohaven Pharmaceuticals, Inc.
Not applicableStudy completedNCT04235673
What this trial is testing

Oral Melatonin as Neuroprotectant in Preterm Infants

Who this might be right for
MalondialdehydeMelatonin
Francesca Garofoli 60
Testing effectiveness (Phase 2)Study completedNCT01854294
What this trial is testing

GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Genervon Biopharmaceuticals, LLC 12
Testing effectiveness (Phase 2)Looking for participantsNCT05122559
What this trial is testing

Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
Emmanuelle Waubant, MD PhD 98
Not applicableStudy completedNCT05807503
What this trial is testing

Evaluation of the Effect of Neuroprotective Drug on Treatment Result in Patients After Traumatic Brain Injury

Who this might be right for
TBI (Traumatic Brain Injury)
Pomeranian Medical University Szczecin 56
Not applicableEnded earlyNCT01486459
What this trial is testing

A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Barwon Health 7
Large-scale testing (Phase 3)Ended earlyNCT00220675
What this trial is testing

Erythropoietin Spinal Cord Compression Randomized Trial

Who this might be right for
Nerve Compression Syndromes
Sunnybrook Health Sciences Centre 7
Not applicableStudy completedNCT00544895
What this trial is testing

Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants

Who this might be right for
Brain Damage, Chronic
Hannover Medical School 600
Testing effectiveness (Phase 2)Study completedNCT01850381
What this trial is testing

Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease

Who this might be right for
Parkinson's Disease
Genervon Biopharmaceuticals, LLC 6
Load More Results